NKTX

NKTX

USD

Nkarta Inc. Common Stock

$1.970-0.040 (-1.990%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$2.010

High

$2.055

Low

$1.960

Volume

0.61M

Company Fundamentals

Market Cap

139.9M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.86M

Exchange

NMS

Currency

USD

52-Week Range

Low $1.31Current $1.970High $3.81

Related News

GlobeNewswire

Nkarta to Participate in November Investor Conferences

SOUTH SAN FRANCISCO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (NASDAQ:NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its

View more
Nkarta to Participate in November Investor Conferences
GlobeNewswire

Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (NASDAQ:NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune

View more
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting